Artigrel-90MG Tab

Tablet

Prevention of atherothrombotic events (heart attack, stroke, cardiovascular death) in adults with acute coronary syndrome (ACS) or history of myocardial infarction; used with low-dose aspirin unless contraindicated.

Ticagrelor is an oral antiplatelet medicine that reversibly inhibits the P2Y12 ADP receptor on platelets. This prevents platelet activation and aggregation, thereby reducing formation of harmful clots in coronary arteries.

Tablet for oral use. Take exactly as prescribed, usually with low-dose aspirin. Can be taken with or without food; swallow with water (may be taken after crushing if unable to swallow as advised by doctor). Do not stop suddenly without medical advice.

Bleeding, bruising, shortness of breath (dyspnoea), headache, dizziness, nausea, diarrhoea, increased uric acid

Increases risk of bleeding—seek urgent help for unusual bleeding, black stools, vomiting blood, severe headache, or weakness. Avoid use in active pathological bleeding or history of intracranial hemorrhage. Use caution in patients with bleeding disorders, recent surgery/trauma, severe liver disease, gout/hyperuricaemia, or asthma/COPD (may worsen breathlessness). Do not discontinue without doctor advice (risk of heart attack/stent thrombosis). Inform surgeon/dentist before procedures.

Other anticoagulants/antiplatelets (warfarin, heparins, DOACs, clopidogrel), NSAIDs (ibuprofen, naproxen), strong CYP3A inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir), strong CYP3A inducers (rifampicin, phenytoin, carbamazepine, phenobarbital), simvastatin/lovastatin (higher levels—dose limits may apply), digoxin (monitor levels), grapefruit juice (may increase levels)

Store below 25°C in a dry place. Protect from moisture and light. Keep out of reach of children.

Brilinta 90 mg Tablet, Ticagrelor 90 mg Tablet (generic), Ticarex 90 mg Tablet, Ticagrelor 90 mg Film-coated Tablet, Ticagrelor 90 Tablet